TRAVERE THERAPEUTICS, INC. (TVTX)

SEC filing

TRAVERE THERAPEUTICS, INC.

TVTX · CIK 1438533

4 · Sep 17, 2026 · EVP, Head of R&D & CMO Inrig Jula sold 44.67K shares at $62.34/share ($2.8M); exercised options for 64.79K shares

EVP, Head of R&D & CMO Inrig Jula sold 44.67K shares at $62.34/share ($2.8M); exercised options for 64.79K shares

xslF345X06/form4-09182026_010947.xml

xslF345X06/form4-09182026_010947.xmlSEC.gov

Graphics and non-inline formats (not embedded below).